Consolidated Statement Of Shareholders' Equity (USD $) Share data in Thousands	Common Stock [Member]	Additional Paid-In Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Total
Balance at Jun. 30, 2014	$ 346,000	$ 356,260,000	$ 112,337,000	$ (93,169,000)	$ (4,785,000)	$ 370,989,000
Balance, shares at Jun. 30, 2014	34,599			(4,841)
Issuance of restricted stock, net of forfeitures and tax withholdings		(384,000)				(384,000)
Issuance of restricted stock, net of forfeitures and tax withholdings, shares	54
Amortization of share-based awards		2,674,000				2,674,000
Issuance of warrants to purchase common stock		14,144,000				14,144,000
Excess tax benefit from share-based awards		154,000				154,000
Net loss attributable to Elizabeth Arden shareholders			(81,489,000)			(81,489,000)
Preferred stock accretion to redemption value			(20,151,000)			(20,151,000)
Preferred stock dividends			(934,000)			(934,000)
Foreign currency translation adjustments					(9,517,000)	(9,517,000)	[1]
Net unrealized cash flow hedging gain					3,305,000	3,305,000	[2]
Balance at Dec. 31, 2014	$ 346,000	$ 372,848,000	$ 9,763,000	$ (93,169,000)	$ (10,997,000)	$ 278,791,000
Balance, shares at Dec. 31, 2014	34,653			(4,841)

[1] Foreign currency translation adjustments are not adjusted for income taxes since they relate to indefinite investments in non-U.S. subsidiaries.

[2] Net of tax expense of $145 and $125 for the three months ended December 31, 2014 and 2013, respectively. Net of tax expense of $623 for the six months ended December 31, 2014, and net of tax benefit of $64 for the six months ended December 31, 2013.